YAYoann Atlas

Yoann Atlas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoann Atlas has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Catherine Monnot

    Universitè Paris Citè, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France

    2 shared publications
  • Corinne Ardidie-Robouant

    Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, PSL Research University, Paris, France

    2 shared publications
  • Laurent Muller

    Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, PSL Research University

    2 shared publications
  • Stéphane Germain

    Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, PSL Research University, Paris, France

    2 shared publications
  • Alain Barret

    Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Paris, France

    1 shared publication
  • Camille Lm Compère

    Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS UMR7241, INSERM U1050, PSL Research University, Paris, France

    1 shared publication

Latest Publications

  • Open Access

    3D vascularized microtumors unveil aberrant ccRCC vasculature and differential sensitivity to targeted treatments

    by Noémie Brassard-Jollive, Yoann Atlas, Camille Lm Compère, Corinne Ardidie-Robouant, Philippe Mailly, Morad El Bouchtaoui, Virginie Lelarge, Guillaume Blot, Nathalie Josseaume, Stéphanie De Oliveira, et al.

    Clear cell renal cell carcinoma (ccRCC) is largely driven by Von Hippel Lindau (VHL) protein deficiency, promoting epithelial-mesenchymal transition, invasion, and hypervascularization, mediated by vascular endothelial growth factor (VEGF) signaling resulting in a structurally abnormal capillary network, which remains insufficiently defined. Previous studies correlating patient outcome with microvascular density yielded diverse results, underscoring the limitations of conventional parameters to fully capture vascular complexity. While VEGF-targeted anti-angiogenic first-line therapies such as sunitinib prolong progression-free survival in metastatic ccRCC, their efficacy is hampered by resistance mechanisms. This study aims to elucidate the three-dimensional architecture of ccRCC-specific vasculature in the tumor microenvironment, and its response to targeted therapies. Analysis of human ccRCC samples identified two distinct vascular structures, markedly differing from tumor capillaries, termed ponds and sheets, which were further characterized in patient-derived xenografts using advanced 3D microscopy on optically cleared samples. Ponds are large, dilated, irregular structures with wide cavity, whereas sheets are thin, elongated, and collapsed structures. To further dissect endothelial network morphogenesis, we developed an innovative in vitro 3D vascularized microtumor model, faithfully recapitulating the aberrant pond architecture. Dynamic live imaging unraveled the temporal relationship between tumor invasion and pond morphogenesis. Additionally, drug sensitivity assays demonstrated that ponds exhibit lower responsiveness to sunitinib compared to tumor capillaries. Altogether, our 3D model not only captures a specific architecture of ccRCC vascular network but also provides mechanistic insight into its development and therapeutic sensitivity. This model offers a promising avenue for personalized treatment assessment and for identification of novel therapeutic strategies. Statement of significance: A co-culture-engineered model integrating tumor spheroid invasion and capillary morphogenesis recapitulates the ccRCC endothelial structures and their response to treatments.


  • Volumetric and Simultaneous Photoacoustic and Ultrasound Imaging With a Conventional Linear Array in a Multiview Scanning Scheme

    by Clément Linger, Yoann Atlas, Rémy Winter, Marine Vandebrouck, Maxime Faure, Théotim Lucas, S. Lori Bridal, Jérôme Gateau

    Volumetric, multimodal imaging with precise spatial and temporal co-registration can provide valuable and complementary information for diagnosis and monitoring. Considerable research has sought to combine 3D photoacoustic (PA) and ultrasound (US) imaging in clinically translatable configurations. However, technical compromises currently result in poor image quality either for photoacoustic or ultrasonic modes. This work aims to provide translatable, high quality, simultaneously co-registered dual-mode PA/US 3D tomography. Volumetric imaging based on a synthetic aperture approach was implemented by interlacing PA and US acquisitions during a rotate-translate scan with a 5-MHz linear array (12 angles and 30-mm translation to image a 21-mm diameter, 19 mm long cylindrical volume within 21 seconds). For co-registration, an original calibration method using a specifically designed thread phantom was developed to estimate 6 geometrical parameters and 1 temporal off-set through global optimization of the reconstructed sharpness and superposition of calibration phantom structures. Phantom design and cost function metrics were selected based on analysis of a numerical phantom, and resulted in a high estimation accuracy for the 7 parameters. Experimental estimations validated the calibration repeatability. The estimated parameters were used for bimodal reconstruction of additional phantoms with either identical or distinct spatial distributions of US and PA contrasts. Superposition distance of the two modes was within < 10% of the acoustic wavelength and a wavelength-order uniform spatial resolution was obtained. This dual-mode PA/US tomography should contribute to more sensitive and robust detection and follow-up of biological changes or the monitoring slower-kinetic phenomena in living systems such as the accumulation of nanoagents.


  • Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms

    by Claudia Umana-Diaz, Cathy Pichol-Thievend, Marion F. Marchand, Yoann Atlas, Romain Salza, Marilyne Malbouyres, Alain Barret, Jérémie Teillon, Corinne Ardidie-Robouant, Florence Ruggiero, et al.